The Coating Solutions by Picosun will Make Medical Implants Last Longer!
By MedTech Outlook | Tuesday, July 02, 2019
The inflammatory reactions between the bodily fluids and the implants have necessitated the need for effective coating solutions, and Picosun offers the best in the market through its AGILE ALD thin film coating.
FREMONT, CA – The surgical implants used to revitalize the functions of the internal organs are often prone to failure due to the reactions occurring at the contact of blood and the implant material. It not only leads to clotting but also can cause inflammatory responses. As a result, the device might end up not performing its intended function.
Several organizations have offered solutions to resolve this problem, but Picosun Group stands among the global providers. The company’s AGILE ALD (atomic layer disposition) thin coating solution is the most advanced ALD thin film coating technology and is used to produce bioactive coatings on surgical implants. The innovative product has revolutionized surgical implants, averting the possibility of clots and reactions. AGILE ALD solutions are used in major industries all over the world. Recently, Picosun was named as one of the “Top 10 Medical Device Manufacturing Solution Providers in Europe - 2019” by MedTech Outlook Magazine.
The healthcare sector has realized the importance of ALD in the last few years. The demand for implants such as artificial hips, knee joints, dental implants, heart stimulators, and so on has increased with the growth of the aging population. Also, the miniaturization of microelectronic and wireless sensor implants to facilitate remote health monitoring and therapeutics has necessitated the development of ALD.
Mr. Juhana Kostamo, Managing Director of Picosun Group, said, “Picosun has worked with medical companies for a long time, for example with Russian-based implant manufacturer Conmet LLC, and with Swedish Nanexa AB, who uses ALD for drug particle surface functionalization for targeted and controlled drug delivery. We also collaborate with several universities where medical ALD technology is developed. These projects have given us unique insight into this business, which is quite different from the semiconductor industries, the most typical ‘playground’ for ALD.”
The inside of the human body is often hostile to foreign substances, and medical implants are no different. Hence, it is necessary to protect the implants from the corrosive body fluids, and this can only be achieved by isolating one from the other. Also, the ions might spark a rejection reaction inside the body, or it might also cause ion leakage.
The ALD offers the perfect solution to this problem through its intrinsically biocompatible, reliably hermetic, and ultra-thin sealing around the implant. The ALD encapsulation not only enhances the longevity of the medical device but also reduces the number of replacement surgeries and maintenance operations.